Updated on Nov 22, 2024 Share
Coming in June: Join Akadeum at CYTO 2021! Akadeum has had two abstracts accepted for CYTO Virtual Interactive 2021, which is planned for June 7-10 this year. This year’s virtual conference promises to be a unique experience, and even though we may not be able to grab a cup of coffee together and chat in person, we’re looking forward to connecting virtually to share these two posters with flow core …
Updated on Nov 22, 2024 Share
Poster Presentation: A Superior Dead Cell Removal Platform Using Akadeum’s BACS Microbubbles Akadeum is pleased to announce that we will be presenting a poster at AAI this year that demonstrates the benefits of using a microbubble approach for dead cell removal. Be sure to visit our poster presentation at AAI to learn more! Overview: Sample preparation and analysis is frequently complicated by the presence of dead cells, leading to negative …
Updated on Nov 4, 2024 Share
Akadeum recently had the opportunity to present a poster presentation at The 12th Scientific Workshop of the Early Detection Research Network. 20th Year of EDRN: Making Cancer Detection Possible. Akadeum’s Microbubbles represent the next generation of isolation technology by offering the tools needed to identify patients early in disease, those with low viral load, or positive samples diluted in a pooled saliva application. Nucleic Acid Extraction with Microbubbles from …
Updated on Nov 22, 2024 Share
Akadeum recently had the opportunity to present a poster presentation at The 12th Scientific Workshop of the Early Detection Research Network. 20th Year of EDRN: Making Cancer Detection Possible. Akadeum’s Microbubbles are a powerful tool for CTC sample preparation that minimizes mechanical force and eliminates magnetization of cells. This poster details an enrichment of rare circulating cells using a microbubble-based preparation. Enrichment of Rare Circulating Cells Using Microbubble-Based Preparation …
Updated on Nov 4, 2024 Share
Akadeum is pleased to announce that we are a semi-finalist in the XPRIZE Rapid Covid Testing competition. We have recently expanded our microbubble platform by functionalizing our revolutionary buoyancy-activated separation technology for RNA isolation in saliva samples. Our goal is to create a workflow that allows for quick and easy RNA extraction in larger volume samples, creating a platform for pooled saliva testing that can be done at scale. Society’s …
Updated on May 18, 2025 Share
Akadeum Life Sciences, Inc., creators of a next generation floatation-based isolation platform, and NanoCellect Biomedical, Inc., a leader in the development and manufacturing of innovative and simple solutions for cell sorting, today jointly announced a new collaboration to improve rare-cell workflows. From single cell genomics to antibody discovery, researchers increasingly require more efficient, rapid, and gentle workflows to advance cellular research applications. Use of the two gentle and high purity …
Updated on Mar 10, 2022 Share
Akadeum closes funding to further commercialize its BACS™ Microbubble platform for next-generation sample preparation applications. Akadeum Life Sciences, Inc. announced an initial close of its Series A financing. The company is pursuing additional investment before final close during Q1 2020. These funds will enable Akadeum to focus its commercial adoption on how to solve longstanding problems in sample preparation. The investment includes several Michigan-based angel groups in addition to venture …
Updated on Nov 22, 2024 Share
Novel Akadeum microbubble technology can be the answer to improved quality and reduced costs across multiple fields of testing. Akadeum Life Sciences, Inc., an Ann Arbor-based biotechnology company, announced today that it has entered into a collaboration with Agilent Technologies, Inc. to work toward a new method of isolating target molecules for detection. Akadeum aims to disrupt the status quo in isolation technology with their buoyant microbubbles. Notably, Akadeum is …
Updated on Nov 22, 2024 Share
Ann Arbor-based biotech company, Akadeum Life Sciences, announced the release of seven new products based on its proprietary microbubble technology. Akadeum Life Sciences today announced at Immunology 2019 the introduction of its first suite of products based on its microbubble technology. Unlike magnetic-based products, microbubbles use buoyancy to gently separate cells of interest within the tube—they simply float to the surface. Feedback from customers who participated in an early access …
Updated on Nov 4, 2024 Share
Akadeum Life Sciences has recently added George Dunbar to our Board of Directors. George has spent his career as an executive and leader of numerous biotech companies. He most recently served as president and CEO of ISTO Biologics, a private cell therapy and biologics company acquired by Thompson Street Capital in St. Louis, Missouri. Prior to ISTO, he was a Venture Partner with Arboretum Ventures, a leading life science venture …